UY27760A1 - Nuevos derivados de pirrolidinio. - Google Patents
Nuevos derivados de pirrolidinio.Info
- Publication number
- UY27760A1 UY27760A1 UY27760A UY27760A UY27760A1 UY 27760 A1 UY27760 A1 UY 27760A1 UY 27760 A UY27760 A UY 27760A UY 27760 A UY27760 A UY 27760A UY 27760 A1 UY27760 A1 UY 27760A1
- Authority
- UY
- Uruguay
- Prior art keywords
- pirrolidinio
- new derivatives
- new
- derivatives
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describe nuevos derivados de pirrolidinio que tienen la estructura química de fórmula general (1) así como procedimientos para su preparación, composiciones farmacéuticas que los comprenden y su uso en terapia como antagonistas de los receptores muscarínicos M3.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200200889A ES2206021B1 (es) | 2002-04-16 | 2002-04-16 | Nuevos derivados de pirrolidinio. |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27760A1 true UY27760A1 (es) | 2003-11-28 |
Family
ID=29225796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27760A UY27760A1 (es) | 2002-04-16 | 2003-04-10 | Nuevos derivados de pirrolidinio. |
Country Status (21)
Country | Link |
---|---|
US (2) | US7192978B2 (es) |
EP (1) | EP1497284A2 (es) |
CN (1) | CN100548978C (es) |
AR (1) | AR039412A1 (es) |
AU (1) | AU2003233967B2 (es) |
BR (1) | BR0309167A (es) |
CA (1) | CA2482536A1 (es) |
CO (1) | CO5611106A2 (es) |
ES (1) | ES2206021B1 (es) |
IL (1) | IL164522A0 (es) |
MX (1) | MXPA04010076A (es) |
MY (1) | MY137535A (es) |
NO (1) | NO20044826L (es) |
NZ (1) | NZ535884A (es) |
PE (1) | PE20040409A1 (es) |
RU (1) | RU2320657C2 (es) |
TW (1) | TW200403237A (es) |
UA (1) | UA79283C2 (es) |
UY (1) | UY27760A1 (es) |
WO (1) | WO2003087094A2 (es) |
ZA (1) | ZA200408335B (es) |
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
TW200519106A (en) | 2003-05-02 | 2005-06-16 | Novartis Ag | Organic compounds |
PE20050231A1 (es) * | 2003-06-24 | 2005-05-20 | Novartis Ag | Derivados de piperidinium y pirrolidinium como antagonistas del receptor muscarinico m3 |
US20050026887A1 (en) * | 2003-07-29 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a steroid |
GB0401334D0 (en) | 2004-01-21 | 2004-02-25 | Novartis Ag | Organic compounds |
US20070179131A1 (en) * | 2004-03-11 | 2007-08-02 | Jian Jin | Novel M3 Muscarinic Acetylcholine Receptor Antagonists |
UY28871A1 (es) | 2004-04-27 | 2005-11-30 | Glaxo Group Ltd | Antagonistas del receptor de acetilcolina muscarinico |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
ES2257152B1 (es) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
RU2379033C2 (ru) * | 2004-05-31 | 2010-01-20 | Лабораториос Альмираль, С.А. | Комбинации, содержащие антимускариновые средства и бета-адренергические агонисты |
GT200500281A (es) | 2004-10-22 | 2006-04-24 | Novartis Ag | Compuestos organicos. |
GB0426164D0 (en) | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
GB0428416D0 (en) * | 2004-12-24 | 2005-02-02 | Novartis Ag | Organic compounds |
GB0428418D0 (en) * | 2004-12-24 | 2005-02-02 | Novartis Ag | Organic compounds |
GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
TW200722418A (en) * | 2005-04-20 | 2007-06-16 | Astrazeneca Ab | Novel compounds |
GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
RU2442771C2 (ru) * | 2005-08-08 | 2012-02-20 | Арджента Дискавери Лтд | Производные бицикло[2,2,1]гепт-7-иламина и их применения |
EP2532679B1 (en) | 2005-10-21 | 2017-04-12 | Novartis AG | Human antibodies against il13 and therapeutic uses |
US20090182033A1 (en) * | 2005-12-16 | 2009-07-16 | Argenta Discovery Ltd. | Cyclic Amine Derivatives and Their Uses |
GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
SI2013211T1 (sl) | 2006-04-21 | 2012-07-31 | Novartis Ag | Purinski derivati za uporabo kot agonisti receptorja adenozina A A |
ES2298049B1 (es) * | 2006-07-21 | 2009-10-20 | Laboratorios Almirall S.A. | Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano. |
CN101516885A (zh) | 2006-09-29 | 2009-08-26 | 诺瓦提斯公司 | 作为pi3k脂质激酶抑制剂的吡唑并嘧啶类化合物 |
TW200825084A (en) | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
WO2008075006A1 (en) * | 2006-12-19 | 2008-06-26 | Astrazeneca Ab | Piperldinum compounds for treatment of obstructive pulmonary diseases ( copd) |
PT2104535E (pt) | 2007-01-10 | 2011-03-31 | Irm Llc | Compostos e composições como inibidores da protease de activação de canal |
WO2008096094A1 (en) * | 2007-02-06 | 2008-08-14 | Argenta Discovery Ltd. | Bicyclor[2.2.1]hept-7-ylamine derivatives as muscarinic m3 receptor modulators |
ES2554646T3 (es) | 2007-02-23 | 2015-12-22 | Theravance Biopharma R&D Ip, Llc | Compuestos de difenilmetilo de amonio cuaternario, de utilidad como antagonistas de receptores muscarínicos |
BRPI0811562A2 (pt) | 2007-05-07 | 2014-12-09 | Novartis Ag | Compostos orgânicos |
KR101517574B1 (ko) * | 2007-09-07 | 2015-05-07 | 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 | 무스카린 수용체 길항제로서 유용한 구아니딘을 함유하는 화합물 |
CA2608561A1 (en) * | 2007-10-29 | 2009-04-29 | Carl Paluszkiewicz | Motorcycle wind deflector accessory support |
ES2602331T3 (es) | 2007-12-10 | 2017-02-20 | Novartis Ag | Pirazin-carboxamidas de tipo amilorida como bloqueantes de ENaC |
US8017617B2 (en) * | 2007-12-14 | 2011-09-13 | Theravance, Inc. | Amidine-containing compounds useful as muscarinic receptor antagonists |
EA201001129A1 (ru) | 2008-01-11 | 2011-02-28 | Новартис Аг | Пиримидины в качестве ингибиторов киназы |
EP2100598A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
US8268834B2 (en) | 2008-03-19 | 2012-09-18 | Novartis Ag | Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme |
MX2010012189A (es) | 2008-05-13 | 2011-03-02 | Astrazeneca Ab | Derivados de quinuclidina como antagonistas del receptor m3 muscarinico. |
ES2535736T3 (es) | 2008-06-10 | 2015-05-14 | Novartis Ag | Derivados de pirazina como bloqueadores de los canales de sodio epitelial |
ES2396023T3 (es) | 2009-01-29 | 2013-02-18 | Novartis Ag | Bencimidazoles sustituidos para el tratamiento de astrocitomas |
JP5902612B2 (ja) | 2009-04-09 | 2016-04-13 | ノバルティス アーゲー | ピロリジニウム塩の調製方法 |
US8389526B2 (en) | 2009-08-07 | 2013-03-05 | Novartis Ag | 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
MX2012001838A (es) | 2009-08-12 | 2012-02-29 | Novartis Ag | Compuestos de hidrazona heterociclico y sus usos para tratar cancer e inflamacion. |
AU2010284254B2 (en) | 2009-08-17 | 2015-09-17 | Intellikine, Llc | Heterocyclic compounds and uses thereof |
JP5775871B2 (ja) | 2009-08-20 | 2015-09-09 | ノバルティス アーゲー | ヘテロ環式オキシム化合物 |
US20110098311A1 (en) | 2009-10-22 | 2011-04-28 | Vertex Pharmaceuticals Incorported | Compositions for treatment of cystic fibrosis and other chronic diseases |
US8247436B2 (en) | 2010-03-19 | 2012-08-21 | Novartis Ag | Pyridine and pyrazine derivative for the treatment of CF |
US8637516B2 (en) | 2010-09-09 | 2014-01-28 | Irm Llc | Compounds and compositions as TRK inhibitors |
WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
US8372845B2 (en) | 2010-09-17 | 2013-02-12 | Novartis Ag | Pyrazine derivatives as enac blockers |
JP2014505088A (ja) | 2011-02-10 | 2014-02-27 | ノバルティス アーゲー | C−METチロシンキナーゼ阻害剤としての[1,2,4]トリアゾロ[4,3−b]ピリダジン化合物 |
WO2012116237A2 (en) | 2011-02-23 | 2012-08-30 | Intellikine, Llc | Heterocyclic compounds and uses thereof |
CN103492384B (zh) | 2011-02-25 | 2016-05-11 | 诺华股份有限公司 | 作为trk抑制剂的化合物和组合物 |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
US8883819B2 (en) | 2011-09-01 | 2014-11-11 | Irm Llc | Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
BR112014006223A8 (pt) | 2011-09-15 | 2018-01-09 | Novartis Ag | 3-(quinolin-6-iltio)-[1,2,4-triazol[4,3-a] piradinas 6-substituídas, seus usos, composições farmacêuticas, e combinação |
JP6165733B2 (ja) | 2011-09-16 | 2017-07-19 | ノバルティス アーゲー | N−置換ヘテロシクリルカルボキサミド類 |
WO2013038373A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine amide derivatives |
WO2013038378A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine amide derivatives |
JP5886433B2 (ja) | 2011-09-16 | 2016-03-16 | ノバルティス アーゲー | 嚢胞性線維症処置のためのヘテロ環式化合物 |
WO2013038381A1 (en) | 2011-09-16 | 2013-03-21 | Novartis Ag | Pyridine/pyrazine amide derivatives |
US20130209543A1 (en) | 2011-11-23 | 2013-08-15 | Intellikine Llc | Enhanced treatment regimens using mtor inhibitors |
US8809340B2 (en) | 2012-03-19 | 2014-08-19 | Novartis Ag | Crystalline form |
CN104245701A (zh) | 2012-04-03 | 2014-12-24 | 诺华有限公司 | 有酪氨酸激酶抑制剂的组合产品和其应用 |
WO2014014698A2 (en) * | 2012-07-16 | 2014-01-23 | Barry University Inc. | Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof |
CN103965178B (zh) * | 2013-02-06 | 2018-03-02 | 中国药科大学 | 作为m3毒蕈碱性受体拮抗剂的吡咯烷鎓衍生物及其在制药中的用途 |
US9073921B2 (en) | 2013-03-01 | 2015-07-07 | Novartis Ag | Salt forms of bicyclic heterocyclic derivatives |
EP2968340A4 (en) | 2013-03-15 | 2016-08-10 | Intellikine Llc | COMBINING KINASE INHIBITORS AND USES THEREOF |
TW201605450A (zh) | 2013-12-03 | 2016-02-16 | 諾華公司 | Mdm2抑制劑與BRAF抑制劑之組合及其用途 |
US10112926B2 (en) | 2014-04-24 | 2018-10-30 | Novartis Ag | Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors |
EP3134395B1 (en) | 2014-04-24 | 2018-01-31 | Novartis AG | Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors |
AU2014391608A1 (en) | 2014-04-24 | 2016-10-27 | Novartis Ag | Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors |
WO2016011658A1 (en) | 2014-07-25 | 2016-01-28 | Novartis Ag | Combination therapy |
CA2954862A1 (en) | 2014-07-31 | 2016-02-04 | Novartis Ag | Combination therapy |
CN105085355B (zh) * | 2015-06-25 | 2017-11-14 | 御盛隆堂药业有限责任公司 | 一种取代的吡咯烷羧酸酯类化合物及其制备方法和应用 |
JP6770005B2 (ja) | 2016-02-10 | 2020-10-14 | 住友化学株式会社 | 1−メチルピロリジン−3−オールの製造方法 |
US10906871B2 (en) | 2016-08-02 | 2021-02-02 | Dermira, Inc. | Processes for making, and methods of using, glycopyrronium compounds |
US20200383960A1 (en) | 2019-06-10 | 2020-12-10 | Novartis Ag | Pyridine and Pyrazine derivative for the Treatment of CF, COPD, and Bronchiectasis |
JP2022547427A (ja) | 2019-08-28 | 2022-11-14 | ノバルティス アーゲー | 置換1,3-フェニルヘテロアリール誘導体及び疾患の治療におけるその使用 |
TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗tslp抗體治療炎性或阻塞性氣道疾病之方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2956062A (en) * | 1959-02-26 | 1960-10-11 | Robins Co Inc A H | Esters of amino alcohols |
US3301869A (en) * | 1960-05-16 | 1967-01-31 | Robins Co Inc A H | Methobromide and hydrochloride of 1-ethyl-3-pyrrolidyl benzilate |
GB1219606A (en) * | 1968-07-15 | 1971-01-20 | Rech S Et D Applic Scient Soge | Quinuclidinol derivatives and preparation thereof |
FR2155927A1 (en) * | 1971-10-15 | 1973-05-25 | Synthelabo | 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity |
JPS5679688A (en) * | 1979-12-04 | 1981-06-30 | Ota Seiyaku Kk | 4-acyloxy-1- 1,3-dioxoran-2-ylmethyl piperidine derivative and its production |
US6130232A (en) * | 1995-10-13 | 2000-10-10 | Banyu Pharmaceutical Coaltd | Substituted piperidine derivatives as muscarinic M3 receptor antagonists |
US6613795B2 (en) * | 1996-11-11 | 2003-09-02 | Christian Noe | Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments |
HU228273B1 (en) | 1996-11-11 | 2013-02-28 | Meda Pharma Gmbh & Co Kg | Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters,process for preparing the same and their use in medicaments |
ES2165768B1 (es) * | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
US7346397B2 (en) * | 2000-06-30 | 2008-03-18 | Cochlear Limited | Cochlear implant |
CA2415468A1 (en) * | 2000-07-11 | 2003-01-10 | Yoshio Ogino | Ester derivatives |
US7174126B2 (en) * | 2002-05-03 | 2007-02-06 | Time Warner Interactive Video Group Inc. | Technique for effectively accessing programming listing information in an entertainment delivery system |
-
2002
- 2002-04-16 ES ES200200889A patent/ES2206021B1/es not_active Expired - Fee Related
-
2003
- 2003-04-10 UY UY27760A patent/UY27760A1/es not_active Application Discontinuation
- 2003-04-11 WO PCT/EP2003/003786 patent/WO2003087094A2/en not_active Application Discontinuation
- 2003-04-11 CN CNB038138921A patent/CN100548978C/zh not_active Expired - Fee Related
- 2003-04-11 US US10/510,680 patent/US7192978B2/en not_active Expired - Fee Related
- 2003-04-11 NZ NZ535884A patent/NZ535884A/en unknown
- 2003-04-11 RU RU2004133371/04A patent/RU2320657C2/ru not_active IP Right Cessation
- 2003-04-11 BR BR0309167-8A patent/BR0309167A/pt not_active IP Right Cessation
- 2003-04-11 CA CA002482536A patent/CA2482536A1/en not_active Abandoned
- 2003-04-11 MX MXPA04010076A patent/MXPA04010076A/es active IP Right Grant
- 2003-04-11 EP EP03727294A patent/EP1497284A2/en not_active Withdrawn
- 2003-04-11 AU AU2003233967A patent/AU2003233967B2/en not_active Ceased
- 2003-04-14 AR ARP030101294A patent/AR039412A1/es unknown
- 2003-04-15 PE PE2003000381A patent/PE20040409A1/es not_active Application Discontinuation
- 2003-04-15 MY MYPI20031408A patent/MY137535A/en unknown
- 2003-04-16 TW TW092108810A patent/TW200403237A/zh unknown
- 2003-11-04 UA UA20041109322A patent/UA79283C2/uk unknown
-
2004
- 2004-10-12 IL IL16452204A patent/IL164522A0/xx unknown
- 2004-10-14 ZA ZA200408335A patent/ZA200408335B/xx unknown
- 2004-10-15 CO CO04104136A patent/CO5611106A2/es not_active Application Discontinuation
- 2004-11-05 NO NO20044826A patent/NO20044826L/no not_active Application Discontinuation
-
2007
- 2007-01-03 US US11/648,581 patent/US20070129420A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NZ535884A (en) | 2007-11-30 |
CO5611106A2 (es) | 2006-02-28 |
US20050282875A1 (en) | 2005-12-22 |
AU2003233967A1 (en) | 2003-10-27 |
TW200403237A (en) | 2004-03-01 |
US20070129420A1 (en) | 2007-06-07 |
RU2004133371A (ru) | 2005-08-10 |
PE20040409A1 (es) | 2004-07-14 |
ES2206021B1 (es) | 2005-08-01 |
EP1497284A2 (en) | 2005-01-19 |
CN100548978C (zh) | 2009-10-14 |
ZA200408335B (en) | 2005-11-02 |
NO20044826L (no) | 2005-01-14 |
RU2320657C2 (ru) | 2008-03-27 |
MXPA04010076A (es) | 2004-12-13 |
AR039412A1 (es) | 2005-02-16 |
IL164522A0 (en) | 2005-12-18 |
AU2003233967B2 (en) | 2009-08-06 |
WO2003087094A2 (en) | 2003-10-23 |
WO2003087094A3 (en) | 2004-03-18 |
ES2206021A1 (es) | 2004-05-01 |
MY137535A (en) | 2009-02-27 |
CN1662527A (zh) | 2005-08-31 |
CA2482536A1 (en) | 2003-10-23 |
US7192978B2 (en) | 2007-03-20 |
BR0309167A (pt) | 2005-01-25 |
UA79283C2 (en) | 2007-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY27760A1 (es) | Nuevos derivados de pirrolidinio. | |
UY27870A1 (es) | Nuevos derivados de quinuclidina-amida | |
ES2195785B1 (es) | Nuevos derivados de piridazin-3(2h)-ona. | |
UY28342A1 (es) | Nuevos compuestos | |
UY28572A1 (es) | Compuestos novedosos | |
AR028948A1 (es) | Compuestos novedosos | |
UY29087A1 (es) | Derivados de adamantilo, composiciones farmaceuticas que los contienen, procesos para su preparacion y uso terapeutico | |
ECSP055671A (es) | Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa | |
UY28150A1 (es) | Agentes terapeuticos | |
ECSP066541A (es) | Nuevos derivados de piridazin-3(2h)-ona | |
UY29234A1 (es) | Derivados de adamantano, composiciones farmacéuticas que los contienen, procedimientos de preparación de ambos y aplicaciones. | |
ECSP034765A (es) | Derivados de bipiperidinilo y su uso como inhibidores de receptores de quimiocina | |
PT1263725E (pt) | Novos compostos | |
UY29875A1 (es) | Compuestos quimicos | |
UY28348A1 (es) | Compuestos novedosos | |
ECSP066426A (es) | Nuevos derivados de pirimidin-2-amina | |
CL2004000918A1 (es) | Compuestos derivados de quinuclidina, antagonistas del receptor muscarinico m3; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para tratar una condicion anti-inflamatoria o alergica, en particular de las vias respiratoria | |
UY29370A1 (es) | Derivados de tiazol, composiciones que lo contienen, procedimientos de preparación y aplicaciones | |
UY27850A1 (es) | Nuevos carbamatos de quinuclidina y composiciones farmacéuticas que los contienen | |
UY28694A1 (es) | Nuevos compuestos | |
PA8575601A1 (es) | Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso | |
UY29892A1 (es) | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones | |
PA8555501A1 (es) | Compuestos de benzimidazol sustituido y su uso para el tratamiento del cancer | |
SE0301701D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150417 |